Author Details

Czyżewski, Krzysztof, Poland

  • Vol 52, No 5 (2021) - ORIGINAL RESEARCH ARTICLE
    High risk of invasive fungal disease in children undergoing hematopoietic cell transplantation or complex anticancer therapy: the adverse role of post-transplant CMV replication
    Abstract  PDF
  • Vol 52, No 2 (2021) - SHORT COMMUNICATION
    Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers
    Details  PDF
  • Vol 52, No 1 (2021) - ORIGINAL RESEARCH ARTICLE
    Impact of ferritin serum concentration on survival in children with acute leukemia: a long-term follow-up
    Abstract  PDF
  • Vol 52, No 3 (2021) - ORIGINAL RESEARCH ARTICLE
    Real-world experience with letermovir in primary prophylaxis of cytomegalovirus in adult patients after hematopoietic cell transplantation: summary of reported data
    Abstract  PDF
  • Vol 52, No 2 (2021) - CLINICAL VIGNETTE
    Extracorporeal photopheresis in a one-year-old child with low body weight
    Details  PDF
  • Vol 53, No 4 (2022) - CLINICAL VIGNETTE
    Double transformation of relapsing juvenile myelomonocytic leukemia to refractory acute myeloid leukemia
    Details  PDF  HTML
  • Vol 53, No 5 (2022) - CLINICAL VIGNETTE
    Clinical remission with autologous recovery after allogeneic hematopoietic cell transplantation for juvenile myelomonocytic leukemia
    Details  PDF
  • Vol 54, No 1 (2023) - ORIGINAL RESEARCH ARTICLE
    Changing risk factors in childhood acute lymphoblastic leukemia: experience from Kujawsko-Pomorski region 1976–2018
    Abstract  PDF  HTML
  • Vol 54, No 1 (2023) - SHORT COMMUNICATION
    Thromboembolic complications associated with COVID-19 infection in children
    Details  PDF  HTML
  • Vol 54, No 1 (2023) - ORIGINAL RESEARCH ARTICLE
    Letermovir use in children after hematopoietic cell transplantation: summary of reported data
    Abstract  PDF  HTML
  • Vol 54, No 2 (2023) - CLINICAL VIGNETTE
    Pneumatosis intestinalis after allogeneic hematopoietic cell transplantation
    Details  PDF  HTML
  • Vol 54, No 4 (2023) - ORIGINAL RESEARCH ARTICLE
    Viral infections after hematopoetic stem cell transplantation in children with acute lymphoblastic leukemia: the Polish experience
    Abstract  PDF  HTML
  • Vol 54, No 3 (2023) - CLINICAL VIGNETTE
    Infection with Fusarium solani presenting as septic shock in child after hematopoietic cell transplantation
    Details  PDF  HTML
  • Vol 54, No 3 (2023) - ORIGINAL RESEARCH ARTICLE
    Invasive fungal disease presenting as septic shock in immunocompromised pediatric and adult patients: summary of reported cases
    Abstract  PDF  HTML
  • Vol 54, No 3 (2023) - CLINICAL VIGNETTE
    Kinetics of CAR-T cells and immunological profile after tisagenlecleucel therapy
    Details  PDF  HTML
  • Vol 54, No 4 (2023) - EDITORIAL
    Pediatric hematooncology in Poland
    Details  PDF  HTML
  • Vol 54, No 5 (2023) - ORIGINAL RESEARCH ARTICLE
    Sclerodermatous manifestation of chronic graft versus host disease: therapy challenges
    Abstract  PDF  HTML
  • Vol 54, No 5 (2023) - CLINICAL VIGNETTE
    Very late relapse of ALL after 14 years: treatment with CAR-T cells
    Abstract  PDF  HTML
  • Vol 54, No 5 (2023) - CLINICAL VIGNETTE
    Prophylaxis with tenofovir in hepatitis-associated severe aplastic anemia treated with hematopoietic cell transplantation
    Abstract  PDF  HTML
  • Vol 54, No 5 (2023) - CLINICAL VIGNETTE
    Nodal form of Rosai-Dorfman-Destombes disease
    Details  PDF  HTML
  • Vol 54, No 5 (2023) - CLINICAL VIGNETTE
    Fecal microbiota transplantation for the treatment of chronic graft versus host
    Abstract  PDF  HTML

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl